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NOVEL APPROACHES TO CANCER CHEMOTHERAPY. Edited by Prasad S. Sunkara.
Orlando, FL, Academic Press, Inc., Publishers, 1984. 383 pp. $65.00.
Apparently without benefit of a predecessory symposium, the editor of this
collection of monographs has selected several topics as representative of areas from
which many of the future advances in the treatment of neoplastic disease will come
forth. His choices are uniformly praiseworthy and meritorious. In each ofthechapters,
which cover such diversified approaches as interferons, monoclonal antibodies, lipo-
some-entrapped drug delivery, and plasma membrane-directed therapies, the authors
have gone to great lengths to discuss the practical limitations of their individual
research in terms of its ultimate clinical utility. Moreover, the issue of selective
toxicity, the bench mark of any new chemotherapeutic modality, is examined to
varying degrees in each ofthe sections, which is commendable indeed.
Undoubtedly the product of a great deal oforganization by Dr. Sunkara, there is a
significant degree of continuity among the separate chapters. For example, both the
first chapter on interferons, by Fleischmann and co-workers, and the chapter on
monoclonal antibodies, by Davis and Rao, give evidence of the genuine difficulties
which still exist in approaches which have already become enshrined in the secular
conscience-while at the same time suggesting that more recent advances (recombi-
nant human y-interferon and human monoclonals) offer real hope for progress in both
diagnosis and treatment. Another example can be found in the section written by Poste
and co-workers and that of Kleinerman and Fidler. After years of significant
accomplishment, George Poste concludes that, overall, the potential for the use of
liposomes in systemic therapies for malignant disease is severely restricted, both by
host or patient physiology and by other, less esoteric factors. One area which is
identified as having potential, however, is the utilization of the observed avidity of
macrophages for lipid vesicles. This is immediately followed by a synopsis ofthe work
of Fidler and co-workers, demonstrating the effectiveness that liposomes containing
macrophage activating factor have when used as an adjuvant to the treatment of
disseminated disease. So it goes through much of this book. Whether one is dealing
with the complexities of prostaglandin-thromboxane-leukotriene biosynthesis (Honn
and Marnett, p. 128) or the impact that potent and specific inhibitors of individual
enzymes could have in treatment (Sunkara and Prakash, p. 94; Petrow and Padilla, p.
270), the effect is the same. This volume is speculative, in a very nonpejorative sense of
that word, and should leave any reader with the notion that real improvements in the
chemotherapy ofcancer are near at hand.
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GILLIES AND DODDS BACTERIOLOGY ILLUSTRATED. Revised by R.R. Gillies. New
York, Churchill Livingstone, Inc., 1985. 224 pp. $28.00. Paperbound.
The fifth edition ofBacteriology Illustratedis intended to be a "supplement to more
complete texts" ofbacteriology, protozoalogy and mycology.
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